News & events

10,000 people could benefit from new migraine drug

Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.

By NIHR Maudsley BRC at 12 Mar 2020

Cluster headache research features on the BBC

Research into cluster headaches taking place at the NIHR Wellcome King's Clinical Research Facility features on BBC Breakfast and BBC Radio 5 live

By NIHR Wellcome King's Clinical Research Facility at 5 May 2017